Valvular Heart Disease in the Community: A European Experience
Section snippets
Organization and Choice of Centers
The Scientific Expert Committee elaborated the study protocol, which was then validated by the Committee for Cardiovascular Databases, Registries, and Surveys of the European Society of Cardiology. National cardiac societies were asked to designate a coordinator who was responsible for the implementation of the protocol, helped translating relevant documents to get approval for the survey, and assisted in the selection of centers.
Tertiary and community centers were included, with or without
Overall Population
Ninety-two centers from 25 countries participated in the survey (Fig 1) and they included 5001 patients. There was a good balance between Western (1407 patients), Mediterranean (1444 patients), and Eastern Europe (1750 patients), while Northern Europe was underrepresented (400 patients). Of the 5001 patients, 1269 underwent a valvular intervention during the survey period in a center participating in the Euro Heart Survey. The type of intervention was stated in 1263 patients: 1099 were on a
Discussion
The Euro Heart Survey gives the opportunity to analyze contemporary characteristics and management of patients with valvular heart disease. The inclusion of patients in a wide range of health care structures throughout Europe enables current practices to be analyzed and compared with guidelines.
Conclusion
This contemporary European overview of patients with valvular heart disease who were managed in a variety of health care structures shows that degenerative etiologies are now by far the most frequent. As a consequence, the burden of valvular heart disease in the elderly is high, in particular in AS and MR, which are the two most frequent native valve diseases. This has important implications in decision-making since too many patients with severe symptomatic valve diseases are denied surgery,
References (49)
- et al.
Burden of valvular heart diseases: a population-based study
Lancet
(2006) - et al.
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease
J Am Coll Cardiol
(2006) - et al.
Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines
Am Heart J
(2007) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
Clinical factors associated with calcific aortic valve disease: cardiovascular health study
J Am Coll Cardiol
(1997) - et al.
Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets
J Thorac Cardiovasc Surg
(2004) - et al.
New observations on the etiology of aortic valve disease: a surgical pathologic study of 236 cases from 1990
Hum Pathol
(1993) - et al.
Evaluation of surgically excised mitral valves: revised recommendations based on changing operative procedures in the 1990s
Hum Pathol
(1993) - et al.
Temporal changes in the causes of aortic stenosis: a surgical pathological study of 646 cases
Mayo Clin Proc
(1987) - et al.
Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample
J Am Coll Cardiol
(1993)
Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes
J Am Coll Cardiol
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
J Am Coll Cardiol
Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study
Lancet
Prediction of operative mortality after valve replacement surgery
J Am Coll Cardiol
Predictors of mortality for patients undergoing cardiac valve replacement in New York State
Ann Thorac Surg
Observed and relative survival after aortic valve replacement
J Am Coll Cardiol
Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction
J Am Coll Cardiol
Choice of prosthetic heart valve for adult patients
J Am Coll Cardiol
Echocardiography predicts embolic events in infective endocarditis
J Am Coll Cardiol
ACC/AHA guidelines for the management of patients with valvular heart disease
Circulation
Guidelines on the management of valvular heart disease
Eur Heart J
A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease
Eur Heart J
Infective endocarditis in Europe: lessons from the Euro Heart Survey
Heart
Decision making in elderly patients with severe aortic stenosis: why are so many denied surgery?
Eur Heart J
Cited by (190)
Global prevalence of depression, anxiety, and stress in cardiac patients: A systematic review and meta-analysis
2023, Journal of Affective DisordersFinite element analysis of mitral valve annuloplasty in Barlow's disease
2022, Journal of BiomechanicsDistribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study
2022, JACC: AsiaCitation Excerpt :Gross domestic product and education level affect disease-related severity and left ventricular dysfunction.20 Additionally, a congenital cause (17%) in older Chinese patients with AS was higher than that (<5%) in European patients.21 Functional AR covered a proportion of patients (15%).
Sutureless versus transcatheter aortic valves in elderly patients with aortic stenosis at intermediate risk: A multi-institutional study
2022, Journal of Thoracic and Cardiovascular SurgeryInitial experience with Portico™ Abbott transcatheter aortic prosthesis. An effective and versatile alternative
2022, Cirugia CardiovascularLiving in disadvantaged neighborhoods linked to less intervention for severe aortic stenosis
2024, Scientific Reports
The Euro Heart Survey on valvular heart disease was funded by the European Society of Cardiology, Dutch Heart Foundation, Fédération Française de Cardiologie/Société Française de Cardiologie, Hellenic Cardiological Society, Swedish Heart and Lung Foundation, European Commission Grant (Infermed/Mansev Project), and Toray Medical Company.